Eye Care News: Recent News in Eye care
![Eye Care News: Recent News in Eye care 1 image 15](https://i0.wp.com/opthametry.com/wp-content/uploads/2023/08/image-15.png?resize=640%2C465&ssl=1)
Eye care News Feed
- Michael Singer, MD, presented 100-week results from the RESTORE trial and shares key takeaways from his presentation at this year's American Society of Retina Specialists (ASRS) meeting.
- A recent study found that adolescents with myopia were twice as likely to develop anxiety and mood disorders.
- Patrick C. Staropoli, MD, discussed his presentation on the clinical characterization of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa while attending the annual ASRS meeting in Stockholm, Sweden.
- The nOCT allows for detailed visualization of the brain's vascular anatomy.
- TFI employs spectral interference technology to image and map the corneal surface.
- Riaz Qureshi, PhD, explains the effects of spin sneaking into systematic reviews and ways the scientific community can better identify it to improve the validity.
- Charles Wykoff, MD, PhD, gives an insight into first-time data from the phase 2, LUNA trial looking at Ixo-Vec at the annual ASRS meeting in Stockholm, Sweden.
- Researchers train deep learning model on OCT scans to ID patients eligible for GA trials.
- The professor was recently given the award for his contributions to advancing vitreoretinal surgery, treatment, research, and patient care.
- A new analysis by researchers at the National Institutes of Health shows the benefit of taking AREDS2 formula in late AMD.
- Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden.
- Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
- This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.
- Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
- Jennifer Lim, MD, FARVO, FASRS, gives an update on the phase 2 DAVIO 2 trial comparing EYP-1901 with aflibercept at the annual ASRS meeting in Stockholm, Sweden.
- Richard B. Rosen, MD, from the New York Eye and Ear Infirmary of Mount Sinai discussed his presentation on sickle cell retinopathy and the measurement with dynamic OCT angiography and quad-fusion adaptive optics imaging at the annual ASRS meeting in Stockholm, Sweden.
- Paolo Antonio Silva, MD, discusses his presentation on diabetic retinopathy lesion types and distribution on ultra-widefield imaging and the risk for disease worsening over time at the American Society of Retina Specialists meeting held in Stockholm, Sweden.
- Danny A. Mammo, MD, sat down with Sydney Crago, Assistant Managing Editor of Modern Retina, to discuss his presentation on intraocular pressure outcomes following suprachoroidal triamcinolone acetonide in patients with glaucoma at the American Society of Retina Specialists meeting held in Stockholm, Sweden.
- The 2-year Phase III data presented at the American Society of Retina Specialists 2024 in Stockholm, Sweden, show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema and diabetic retinopathy.
- Data in early-stage patients was presented at 42nd American Society of Retina Specialists Annual Scientific Meeting, being held in Stockholm, Sweden.
- When selecting progressive lenses for your customer, you have the choice between fixed and variable corridor designs. Each design has its own advantages and disadvantages, and the key to maximizing the benefits of each is to prioritize good customer service by listening to your client. Understanding how to best assist your customer, whether it be […] This story Fixed vs. Variable Corridor Design – appears on The Optical Journal.
- The International Opticians Association in collaboration with Silmo can announce the 2024 finalists for the coveted International Optician of The Year award. The winner of this year’s award will take the crown from 2023 laureate, Jean Francois Porte from France. Chosen from a wide range of opticians around the world, nominated by colleagues and peers, […] This story Shortlist for IOA SILMO Optician of the Year 2024 – appears on The Optical Journal.
- John Seegers of Optician Works and Laramy-K, have graciously shared some of their awesome videos with us to share with you. John is one of the best trainers of opticians and his video series has received acclaim from coast to coast, helping thousands of opticians pass certification and licensing exams. This week’s video is Surviving Optical Retail […] This story Teachable Tuesday – Surviving Optical Retail – appears on The Optical Journal.
- read on, the Swiss reading glasses design company at the forefront of eyewear innovation, has appointed a new distribution partner for ‘read on light’ reading glasses in Switzerland and Austria, to advance market growth and expansion in Europe. Prolens AG, who will sell ‘read on light’ directly to Swiss and Austrian (via Bilosa) customers, are […] This story read on Appoints First European Distribution Partner – appears on The Optical Journal.
- Enhancing expertise, stimulating innovation, and championing the sector: SILMO also promotes tomorrow’s talent with the Optical Design Contest. Open to design school students around the world, the third edition of the contest focuses on accessory glasses that, aside from correcting and protecting the wearer’s vision, explore new functionalities and uses. Chaired by Olivier Jault and […] This story SILMO 2024 Optical Design Contest – appears on The Optical Journal.
- Marcolin and Max Mara hosted a special luncheon celebrating the summer season and MAX MARA EYEWEAR at The Pridwin Hotel on Shelter Island last week. The luncheon featured the new Spring/Summer 2024 Sun Collection from Max Mara eyewear, defined by timeless elegance and feminine sophistication. Inspired by two icons – internationally renowned architect Eileen Gray and […] This story Max Mara Eyewear Celebrates Summer – appears on The Optical Journal.
- Eco Eyewear announced its collaboration with Waste Free Oceans (WFO) and a local recycler to construct a floating barrier in Tanzania. This strategic partnership focuses on removing plastic waste from rivers, promoting sustainable practices, and making a positive environmental impact in Tanzania. In an exciting development, WFO’s local partner, The Recycler, has successfully constructed a […] This story Waste Free Oceans & Eco Eyewear – appears on The Optical Journal.
- IOT, a leader in innovative lens technology, is proud to announce the launch of its groundbreaking Neochromes with Camber Technology in the US and Canada. This innovative combination of technologies offers wearers the best of both worlds: the fast activation and high UV protection of Neochromes photochromic lenses, and the superior optical quality of Camber* […] This story IOT Unveils Neochromes with Camber Technology – appears on The Optical Journal.
- OGI Kids has always been about translating the individuality, fun, and wearability of OGI styles into pint-sized packaging for smaller faces. As OGI has explored metals, OGI Kids is keeping pace with new frames that bring studious silhouettes and vibrant colors together. Mast and Viking have the classic staying power of well-crafted ships, with adjustable […] This story OGI Kids – Style Is Never On Summer Break – appears on The Optical Journal.
- The 2025 SightCare Independent Optician Awards celebrating the independent spirit has opened for applications. The SightCare Awards recognize the best independent opticians from the length and breadth of the UK. Independent practitioners and their staff enter learning initiatives and independent business content in various categories for recognition of excellence. The 2025 Awards categories included: Independent […] This story 2025 SightCare Awards Launched – appears on The Optical Journal.
- Schoenbrun will retire from the organization in December after coming out of retirement to serve as the interim executive director for OGS in 2022.
- According to the company, the tuck-in acquisition will help expand its surgical presence in the United States and contribute to its leading position in dry eye.
- Focusing on the care of patients with MGD, Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide key takeaways on treatment practices.
- Dry eye experts provide comprehensive insights on the role of in-office procedural therapies.
- The quality of options for patients has improved in recent years.
- The 2-year Phase III data demonstrates Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema and diabetic retinopathy.
- From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.
- Catch up on what happened in optometry during the week of July 15-July 19.
- TEAM-OGS gives practices more fundraising opportunities to end preventable blindness and vision impairment globally throughout the year.
- Removing drops improves adherence and comfort for most patients.
- Organization corresponding secretary Babirekere Bakama weighs in on her favorite learning opportunities at this year’s NOA Convention.
- An introduction to cerebral visual impairment.
- Utilizing artificial intelligence may provide feasibility assessments, data-driven protocol design, and cost reduction opportunities.
- Cofounders Camille F. Cohen, OD, FAAO, and Janis James, OD, FAAO discuss what the organization has been up to at the National Optometric Association Convention.
- Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.
- Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).
Follow us in Facebook